Previous 10 | Next 10 |
-- Company to Host Conference Call and Webcast Today at 8:00 a.m. ET SHANGHAI and SAN FRANCISCO, March 01, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today reported financial results for the second half ...
BAMCO’s 13F portfolio value increased from $32.58B to $40.42B this quarter. Ron Baron decreased Tesla while increasing RingCentral and Amazon during the quarter. Their top five positions are at ~26% of the overall portfolio. For further details see: Tracking Ron B...
SHANGHAI and SAN FRANCISCO, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today announced that it will report financial results for the full year ended December 31, 2020, and provide a corporate update...
Zai Lab ([[ZLAB]] +2.8%) is up ~2.7% after Jefferies rated the stock with a buy citing ‘huge biotech tailwinds’ in China where, according to analysts, the biopharma drug market is set to reach $80B in this decade from $30B.The price target derived from a combination of sum-of-th...
SHANGHAI and SAN FRANCISCO, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today announced that senior management from Zai Lab will be presenting in the following upcoming virtual investor conferences i...
Even though NIO (NIO) has delivered spectacular returns over the past year, Tencent (TME), Bilibili (BILI), and Zai Lab (ZLAB) have outperformed the stock so far this year. Based on growing market demand and impressive financials, we believe these Chinese stocks are poised to generate healthy...
ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Optimism over a return to normal economic activity global...
ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. 2020 was a year of monumental progress in renewable energ...
The biotechnology sector has been the focus of investors since the outbreak of the COVID-19 pandemic. Initially, all eyes were on accurate COVID-19 testing, followed by an anxious wait for vaccines. The speedy development of coronavirus vaccines then opened eyes to possible cures for other ra...
Zai Lab Secures Exclusive Right to Develop and Commercialize TPX-0022, Turning Point’s MET/SRC/CSF1R Inhibitor, in Greater China Turning Point to Receive $25 Million Upfront, with Up to Approximately $336 Million in Potential Milestone Payments and Royalties ...
News, Short Squeeze, Breakout and More Instantly...
First and only NMPA-approved subcutaneous (SC) injectable providing additional flexibility and optionality for gMG patients in China Consistent clinical benefit and safety profile of efgartigimod SC compared to IV demonstrated in Phase 3 ADAPT-SC study Zai Lab Limited (NASDAQ: Z...
Manuscript represents the first publication from China’s gynecology oncology field to be published in Cell Publication highlights first-time learnings about the landscape of ovarian cancer microenvironment stratified by HRD and how a PARP inhibitor perturbs it Data suggest ...
2024-07-05 18:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...